Veracyte, Inc.

NasdaqGM:VCYT Stock Report

Market Cap: US$3.3b

Veracyte Management

Management criteria checks 4/4

Veracyte's CEO is Marc Stapley, appointed in Jun 2021, has a tenure of 4.58 years. total yearly compensation is $6.82M, comprised of 9.9% salary and 90.1% bonuses, including company stock and options. directly owns 0.17% of the company’s shares, worth $5.71M. The average tenure of the management team and the board of directors is 3.9 years and 4.8 years respectively.

Key information

Marc Stapley

Chief executive officer

US$6.8m

Total compensation

CEO salary percentage9.90%
CEO tenure4.6yrs
CEO ownership0.2%
Management average tenure3.9yrs
Board average tenure4.8yrs

Recent management updates

Recent updates

Veracyte, Inc. (NASDAQ:VCYT) Stock Catapults 27% Though Its Price And Business Still Lag The Industry

Nov 22
Veracyte, Inc. (NASDAQ:VCYT) Stock Catapults 27% Though Its Price And Business Still Lag The Industry

Veracyte, Inc.'s (NASDAQ:VCYT) Price Is Right But Growth Is Lacking After Shares Rocket 27%

Aug 30
Veracyte, Inc.'s (NASDAQ:VCYT) Price Is Right But Growth Is Lacking After Shares Rocket 27%

Veracyte: Q2 Earnings Brings My Position Out Of Mothballs

Aug 26

Veracyte, Inc.'s (NASDAQ:VCYT) Shares Lagging The Industry But So Is The Business

Jun 15
Veracyte, Inc.'s (NASDAQ:VCYT) Shares Lagging The Industry But So Is The Business

Veracyte, Inc. Just Beat EPS By 260%: Here's What Analysts Think Will Happen Next

May 10
Veracyte, Inc. Just Beat EPS By 260%: Here's What Analysts Think Will Happen Next
User avatar

Decipher, Afirma And MRD Tests Will Broaden Future Markets

Veracyte’s Decipher test expansion and updated NCCN guidelines could drive significant revenue growth and market share in the prostate cancer segment.

Shareholders Can Be Confident That Veracyte's (NASDAQ:VCYT) Earnings Are High Quality

Mar 08
Shareholders Can Be Confident That Veracyte's (NASDAQ:VCYT) Earnings Are High Quality

Veracyte, Inc. (NASDAQ:VCYT) Looks Inexpensive After Falling 26% But Perhaps Not Attractive Enough

Mar 04
Veracyte, Inc. (NASDAQ:VCYT) Looks Inexpensive After Falling 26% But Perhaps Not Attractive Enough

Veracyte, Inc.'s (NASDAQ:VCYT) Intrinsic Value Is Potentially 50% Above Its Share Price

Jan 09
Veracyte, Inc.'s (NASDAQ:VCYT) Intrinsic Value Is Potentially 50% Above Its Share Price

Veracyte: Getting Frothy

Dec 11

Veracyte, Inc. (NASDAQ:VCYT) Surges 25% Yet Its Low P/S Is No Reason For Excitement

Dec 01
Veracyte, Inc. (NASDAQ:VCYT) Surges 25% Yet Its Low P/S Is No Reason For Excitement

Veracyte, Inc.'s (NASDAQ:VCYT) Price Is Right But Growth Is Lacking After Shares Rocket 42%

Aug 18
Veracyte, Inc.'s (NASDAQ:VCYT) Price Is Right But Growth Is Lacking After Shares Rocket 42%

Veracyte, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Aug 09
Veracyte, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Veracyte, Inc.'s (NASDAQ:VCYT) Intrinsic Value Is Potentially 76% Above Its Share Price

Jul 02
Veracyte, Inc.'s (NASDAQ:VCYT) Intrinsic Value Is Potentially 76% Above Its Share Price

Veracyte, Inc.'s (NASDAQ:VCYT) Price Is Right But Growth Is Lacking

Jun 06
Veracyte, Inc.'s (NASDAQ:VCYT) Price Is Right But Growth Is Lacking

Veracyte, Inc. (NASDAQ:VCYT) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates

May 09
Veracyte, Inc. (NASDAQ:VCYT) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates

Lacklustre Performance Is Driving Veracyte, Inc.'s (NASDAQ:VCYT) Low P/S

Apr 18
Lacklustre Performance Is Driving Veracyte, Inc.'s (NASDAQ:VCYT) Low P/S

A Look At The Intrinsic Value Of Veracyte, Inc. (NASDAQ:VCYT)

Mar 18
A Look At The Intrinsic Value Of Veracyte, Inc. (NASDAQ:VCYT)

CEO Compensation Analysis

How has Marc Stapley's remuneration changed compared to Veracyte's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2025n/an/a

US$30m

Jun 30 2025n/an/a

US$26m

Mar 31 2025n/an/a

US$33m

Dec 31 2024US$7mUS$675k

US$24m

Sep 30 2024n/an/a

-US$9m

Jun 30 2024n/an/a

-US$54m

Mar 31 2024n/an/a

-US$68m

Dec 31 2023US$7mUS$650k

-US$74m

Sep 30 2023n/an/a

-US$50m

Jun 30 2023n/an/a

-US$29m

Mar 31 2023n/an/a

-US$30m

Dec 31 2022US$5mUS$625k

-US$37m

Sep 30 2022n/an/a

-US$43m

Jun 30 2022n/an/a

-US$49m

Mar 31 2022n/an/a

-US$48m

Dec 31 2021US$6mUS$350k

-US$76m

Compensation vs Market: Marc's total compensation ($USD6.82M) is about average for companies of similar size in the US market ($USD6.90M).

Compensation vs Earnings: Marc's compensation has been consistent with company performance over the past year.

CEO

Marc Stapley (55 yo)

4.6yrs
Tenure
US$6,816,368
Compensation

Mr. Marc A. Stapley serves as Chief Executive Officer at Veracyte, Inc. since June 1, 2021 and serves as its Director since June 08, 2021. He served as the Chief Executive Officer of Helix OpCo, LLC from A...

Leadership Team

NamePositionTenureCompensationOwnership
Marc Stapley
CEO & Director4.6yrsUS$6.82m0.17%
$ 5.7m
Rebecca Chambers
Executive VP & CFO4.5yrsUS$3.65m0.046%
$ 1.5m
Phillip Febbo
Chief Scientific & Medical Officer2.3yrsUS$2.79m0.021%
$ 685.9k
Annie McGuire
Executive VP3.9yrsUS$3.09m0.00096%
$ 31.9k
John Leite
Global Chief Commercial Officer3.3yrsUS$3.09m0.010%
$ 339.8k
Keith Gligorich
Senior Vice President of Global Operations1.2yrsno datano data
Jonathan Wygant
VP & Chief Accounting Officer3.9yrsno data0.0054%
$ 179.4k
Steven French
Senior VP & Chief Information Officer4yrsno datano data
Karen Possemato
Senior Vice President of Corporate Marketing2yrsno datano data
Corinne Danan
Senior Vice President2.8yrsno datano data
Beverly Alley
VP & Corporate Controller5yrsUS$1.29mno data
Shayla Gorman
Director of Investor Relationsno datano datano data
3.9yrs
Average Tenure
54yo
Average Age

Experienced Management: VCYT's management team is considered experienced (3.9 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Marc Stapley
CEO & Director4.6yrsUS$6.82m0.17%
$ 5.7m
Karin Eastham
Independent Director13.1yrsUS$325.00k0.0053%
$ 178.0k
Evan Jones
Independent Director17.9yrsUS$325.00k0.025%
$ 843.6k
Robert Epstein
Independent Chair11yrsUS$360.00k0.067%
$ 2.2m
Jens Holstein
Independent Director5.4yrsUS$327.50k0.023%
$ 752.8k
David Shafer
Independent Director1.3yrsUS$519.16kno data
Edison Liu
Member of Scientific Advisory Boardno datano datano data
Muna Bhanji
Independent Director4.8yrsUS$310.00k0.038%
$ 1.3m
Thomas Miller
Independent Director1.3yrsUS$518.33kno data
Eliav Barr
Independent Director3.4yrsUS$305.00k0.044%
$ 1.5m
4.8yrs
Average Tenure
62yo
Average Age

Experienced Board: VCYT's board of directors are considered experienced (4.8 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/01/02 17:54
End of Day Share Price 2026/01/02 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Veracyte, Inc. is covered by 24 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Sung Ji NamBTIG
Kyle MiksonCanaccord Genuity
Bryan BrokmeierCantor Fitzgerald & Co.